EditorialMaister Peter Lowe (c1550–1610). JAMA1966; 195: 386–387.
2.
PeterLowe. Discourse of the Whole Art of Chirurgerie. 1st ed. London: Thos. Purfoot1597.
3.
BrownJ. ‘Rab and His Friends’ In Horae Subsecivae 2nd series. Edinburgh: D. Douglas1889: 365–387.
4.
GodleeRJ. Lord Lister. London: Macmillan1917.
5.
HalstedWS. The result of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889-January 1894. Johns Hopkins Hospital Reports1895; 4: 297–350.
6.
McWhirterR. The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast. Br J Radiol1948; 21: 599–610.
7.
HandleyWS. Cancer of the breast and its operative treatment. London: John Murray1906.
8.
BrinkleyDHaybittleJL. The curability of breast cancer. Lancet1975; 2: 95–97.
9.
BrinkleyDHaybittleJL. The concept of cure in breast cancer. The High Risk Patient with Breast Cancer. Ed McCrackenMM. Yorkshire Breast Cancer Group1981.
10.
LanglandsAOPocockSJKerrJRGoreSM. Long-term survival of patients with breast cancer: a study of the curability of the disease. Br. Med. J.1979; 2: 1247–1251.
11.
FisherERGregorioRMFisherB. The pathology of invasive breast cancer. Cancer1975; 36: 1–85.
12.
BloomHJGRichardsonWW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer1957; 11: 359–369.
13.
CutlerSJBlackMMMorkTHarvelSFreemanC. Further observations on prognostic factors in cancer of the female breast. Cancer1969; 24: 653–667.
14.
LaneNGoskelHSalernoRAHaagensonCD. Clinico-pathologic analysis of the surgical curability of breast cancers: a minimum ten-year study of a personal series. Ann Surg1961153: 483–498.
15.
WaltAJSinghakowintaABrooksSCCortezA. The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery197680: 506–512.
16.
ShivasAADouglasJG. The prognostic significance of elastosis in breast carcinoma. J R Coll Surg Edin1972; 17: 315–320.
17.
BlackMMOplerSRSpeerFD. Survival in breast cancer cases in relation to the structure of the primary tumour and regional lymph nodes. Surg Gynecol Obstet1955; 100: 543–551.
18.
BlackMMKerpesSSpeerFD. Lymph node structure in patients with cancer of the breast. Am J Pathol1953; 29: 505–521.
19.
LeeDDixonJMPageDHelenJ StewartForrestAPM. A study of the histology of patients surviving 20 years after mastectomy for carcinoma of the breast1981. In preparation.
20.
ForrestAPMBlackRBHumeniukV. Preoperative assessment and staging of breast cancer: preliminary communication. J R Soc Med1980; 73: 561–565.
21.
HumeniukVHawkinsRAForrestAPM. The quantitative value of oestrogen receptor levels in primary breast cancer. Brit J Surg1980; 67: 366–367.
22.
HawkinsRAHillAFreemanB. A simple method for determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta1975; 64: 203–210.
23.
CookeTGeorgeDShieldsRMaynardPGriffithsK. Oestrogen receptors and prognosis in early breast cancer. Lancet1979; 1: 995–997.
24.
MaynardPVBlarneyRWElstonCWHaybittleJLGriffithsK. Estrogen-receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res1978; 38: 4292–4295.
25.
NemotoTVanaJBedwaniRNBakerHWMcGregorFHMurphyGP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer1980; 45: 2917–2924.
26.
BulbrookRDWangDYMillisRRHaywardJL. The possibility of accurate prediction of recurrence rates after mastectomy. Eur J Cancer Suppl1980; 35–38.
27.
BlameyRDaviesCJElstonCWJohnsonJHaybittleJLHaywardPV. Prognostic factors in breast cancer—the formation of prognostic index. Clin Oncol1979; 5: 1–10.
28.
ElstonCW. Pathological grading and its relation to oestrogen receptors as a prognostic factor in the high risk patient with breast cancer. Ed McCrackenM. Yorkshire Breast Cancer Group1980.
29.
Nissen-MeyerRKjellgrenKMalmioKManssonBNorinT. Surgical adjuvant chemotherapy. Results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer1978; 41: 2088–2098.
30.
BonadonnaGValagussaP. Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med1981; 304: 10–15.
31.
FisherBCarbonePEconomovSG. 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med1976; 292: 117–122.
32.
CarterSK. Adjuvant chemotherapy of breast cancer. N Engl J Med1981; 304: 45–47.
33.
Coordinating Committee: Clinical trials of the treatment of breast cancer in Britain and Ireland. Br Med J1977; 1: 361–364.
34.
BeatsonGT. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet1896; 2: 104–107 and 162–165.
35.
HugginsCDaoTL. Adrenalectomy and oophorectomy in treatment of advanced carcinoma of the breast. JAMA1953; 151: 1388–1394.
36.
OlivecronaHLuftR. Experiences with hypophysectomy in cancer of the breast. Ann R. Coll Surg Engl1957; 20: 267–279.
37.
ForrestAPMPeebles-BrownDA. Pituitary-radon implant for breast cancer. Lancet1955; 1: 1054–1055.
JensenEVJacobsonHI. Fate of steroid estrogens in target tissues. In Biological Activities of Steroids in relation to Cancer. Eds PincusGVollmerRV. New York: Academic Press1960; 1: 161–174.
40.
HawkinsRARobertsMMForrestAPM. Oestrogen receptors in breast cancer: current status. Br J Surg1980; 67: 153–169.
41.
JonesDCameronEHDGriffithsKGleaveENForrestAPM. Steroid metabolism by human breast tumours. Biochem J1970; 116: 919–921.
42.
AdamsJBLiK. Biosynthesis of 17 B-oestradiol in human breast carcinoma tissue and a novel method for its characterization. Br J Cancer1975; 31: 429–438.
43.
MillerWRForrestAPM. Oestradiol synthesis by a human breast carcinoma. Lancet1974; 2: 866–869.
44.
MillerWRHumeniukVKellyEW. Dehydroepiandrosterone sulphate in breast secretions. J Steroid Biochem1980; 13: 145–151.
45.
RazuUGangulyMLevitzM. Estriol conjugates in human breast cyst fluid and in serum of premenopausal women. J Clin Endocrinol Metab1977; 45: 429–434.
46.
ColeMP. A clinical trial of an artificial menopause in carcinoma of the breast. In Hormones and Breast Cancer. Eds NamerMLalanneCM. Paris: Inserm P1976: 143–150.
47.
Nissen-MeyerR. Adjuvant cytostatic and endocrine therapy: increased cure rate or delayed manifest disease. Commentaries on Research in Breast Disease. Eds BulbrookRDJaneTaylor D, New York: Alan R. Liss Inc.1979; 1: 95–109.
48.
FisherB. Status of adjuvant therapy: results of the National Surgical Adjuvant Breast Project Studies on oophorectomy, postoperative radiation therapy and chemotherapy. Cancer1971; 28: 1654–1658.
49.
MeakinJWAlltWECBealeFA. Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. Can Med Assoc J1979; 120: 1221–1229.
50.
DaoTLNemotoTChamberlainABrossI, Adrenalectomy with radical mastectomy in the treatment of high-risk breast cancer. Cancer1975; 35: 478–482.
51.
HubayCAPearsonOHMarshallJS. Adjuvant chemotherapy, antioestrogen therapy and immunotherapy for stage II breast cancer. Eur J Cancer Suppl1980; 189–195.
52.
SmithIEFitzharrisBHMcKinnaJA. Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet1978; 2: 646–649.
53.
CantELSmithAFSumerlingMD. Superstaging in breat cancer—a correlation of lymph nodes, histology and investigations designed to detect occult metastic disease. World J Surg1977; 1: 303–305.
54.
BlackRBMaureenRoberts MHelenJ Stewart. The search for occult metastases in breast cancer; does it add to established staging methods?Aust NZ J Surg1980; 50: 574–579.
55.
Preliminary statement by British Breast group on bone scanning. Bone scanning in breast cancer. Br Med J1978; 2: 180–181.
56.
International Union Against Cancer. TNM Classification of Malignant Tumours. 3rd ed. Geneva; UICC1978.
57.
PatersonRRussellMH. Clinical trials in malignant disease. Part III—breast cancer: evaluation of postoperative radiotherapy. J Fac Radiol1959; 10: 175–180.
58.
EassonEC. Post-operative radiotherapy in breast cancer. In Prognostic Factors in Breast Cancer. Eds ForrestAPMKunklerPB. Edinburgh, London: E. S. Livingston Ltd. 1968: 118–127.
59.
LipsettM. Postoperative radiation for women with cancer of the breast and positive axillary lymph nodes; should it continue?N Engl J Med1981; 304: 112–114.
60.
Cancer Research Campaign Working Party: Cancer Research Campaign (King's/Cambridge) Trial for early breast cancer. A detailed update at the tenth year. Lancet1980; 2: 55–60.
61.
ForrestAPMGleaveENRobertsMMHenkJMGravelleIH. A controlled trial of conservative treatment for early breast cancer. Proc R Soc Med1970; 63: 107.
62.
ForrestAPMRobertsMMStewartHJ. Selection of local therapy for primary breast cancer by lower axillary node histology. Eur J Cancer Suppl1980; 1: 237–242.
63.
DuncanWLanglandsAOForrestAPM. New Edinburgh Primary Breast Cancer Trials. Report by Coordinating Committee. Br J Cancer1975; 32: 628–630.
MaguireGPLeeEGBevingtonDJ. Psychiatric problems in the first year after mastectomy. Br Med J1978; 1: 963–965.
66.
MaguireGPTaitABrookeMThomasCSellwoodR. Effect of counselling on the psychiatric morbidity associated with mastectomy. Br Med J.1980; 281: 1454–1456.
67.
PierquinBBailletFWilsonJF. Radiation therapy in the management of primary breast cancer. Am J Roentgenol1976; 127: 645–648.
68.
CalleRPilleronJPSchliengerPVilcoqJR. Conservative management of operable breast cancer. Ten years experience at the Foundation Clinic. Cancer1978; 42: 2045–2053.
69.
HellmanSHarrisJRLeveneMB. Radiation therapy of early carcinoma of the breast without mastectomy. Cancer1980; 46: 988–994.
70.
KeynesG. Conservative treatment of cancer of the breast. Br Med J1937; 2: 643–647.
71.
BaclesseF. Roentgen therapy as the sole method of treatment of cancer of the breast. Am J Roentgenol1949; 62: 311–319.
72.
MustakallioS. Conservative treatment of breast carcinoma-review of 25 years follow-up. Clin Radiol1972; 23: 110–116.
73.
PetersMV. Cutting the ‘Gordian Knot’ in early breast cancer. Ann R Coll Phys Surg Canada1975: 186–192.
74.
HaywardJL. The Guy's trial of treatment of ‘early’ breast cancer. World J Surg1977; 1: 314–316.
75.
News Bulletin of the British Cancer Trials Coordinating Sub-Committee (1980). No. 1 September 1980. Prepared by Dr HJ Stewart.
76.
ShapiroS. Evidence on screening for breast cancer from a randomized trial. Cancer1977; 39: 2772–2782.
77.
ForrestAPMRobertsMM. Screening for breast cancer. Br J Hosp Med1980; 8: 8–21.
78.
OwenAWMCForrestAPMAndersonTJSamuelEYoungGBScottAM. Breast screening and surgical problems. Br J Surg1977; 64: 725–728.